China Biotech Services Holdings Limited (HKG:8037)
Hong Kong · Delayed Price · Currency is HKD 0.6200
0.00 (0.00%)
Jul 31, 2026, 2:39 PM HKT
HKG:8037 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 605 | 771 | 498 | 742 | 1,108 | 1,329 | |
Market Cap Growth | -13.89% | 54.90% | -32.91% | -33.04% | -16.67% | 5.85% |
Enterprise Value | 952 | 946 | 622 | 678 | 1,090 | 1,342 |
Last Close Price | 0.62 | 0.79 | 0.51 | 0.77 | 1.14 | 1.37 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 4.29 | 68.57 |
PS Ratio | 8.23 | 10.49 | 7.06 | 3.50 | 0.60 | 2.13 |
PB Ratio | 3.88 | 4.95 | 2.05 | 1.51 | 1.34 | 2.85 |
P/TBV Ratio | 11.91 | 15.17 | 3.95 | 2.49 | 2.61 | 6.86 |
P/FCF Ratio | - | - | - | 5.61 | 2.96 | 46.99 |
P/OCF Ratio | - | - | - | 3.87 | 2.30 | 32.82 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 12.95 | 12.87 | 8.83 | 3.20 | 0.59 | 2.15 |
EV/EBITDA Ratio | - | - | - | - | 1.21 | 5.48 |
EV/EBIT Ratio | - | - | - | - | 1.29 | 7.08 |
EV/FCF Ratio | - | - | - | 5.12 | 2.91 | 47.43 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.54 | 2.54 | 0.78 | 0.21 | 0.10 | 0.14 |
Debt / EBITDA Ratio | - | - | - | - | 0.09 | 0.26 |
Debt / FCF Ratio | - | - | - | 0.76 | 0.22 | 2.37 |
Net Debt / Equity Ratio | 2.46 | 2.46 | 0.70 | 0.06 | -0.01 | -0.18 |
Net Debt / EBITDA Ratio | -6.03 | -6.03 | -1.54 | -0.39 | -0.01 | -0.35 |
Net Debt / FCF Ratio | -2.03 | -2.03 | -0.83 | 0.21 | -0.03 | -3.01 |
Asset Turnover | 0.12 | 0.12 | 0.12 | 0.20 | 1.70 | 0.77 |
Inventory Turnover | 3.22 | 3.22 | 11.39 | 12.69 | 63.98 | 51.75 |
Quick Ratio | 0.07 | 0.07 | 0.21 | 0.73 | 1.54 | 1.09 |
Current Ratio | 0.23 | 0.23 | 0.33 | 1.64 | 1.61 | 1.22 |
Return on Equity (ROE) | -40.61% | -40.61% | -68.71% | -21.36% | 109.19% | 27.11% |
Return on Assets (ROA) | -7.49% | -7.49% | -12.98% | -6.85% | 48.39% | 14.71% |
Return on Invested Capital (ROIC) | -13.71% | -15.55% | -26.61% | -17.51% | 115.24% | 45.35% |
Return on Capital Employed (ROCE) | -20.70% | -20.70% | -36.70% | -23.20% | 91.40% | 39.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -11.37% | -8.92% | -39.82% | -12.87% | 23.30% | 1.46% |
FCF Yield | -31.09% | -24.40% | -40.90% | 17.84% | 33.81% | 2.13% |
Dividend Yield | - | - | - | - | 0.88% | - |
Buyback Yield / Dilution | -0.75% | -0.75% | -0.55% | - | 0.15% | 0.39% |
Total Shareholder Return | -0.75% | -0.75% | -0.55% | - | 1.03% | 0.39% |